Status:
COMPLETED
Vitamin D Regulates the Expression of Glucocorticoid Receptors in Blood of Severe Asthmatic Patients
Lead Sponsor:
Dubai Health Authority
Collaborating Sponsors:
McGill University
Conditions:
Effect of Drug
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Vitamin D (VitD) deficiency is a significant public health concern in many areas around the globe which has been associated with many immune-mediated diseases, including asthma. Severe asthma has been...
Detailed Description
Vitamin D (VitD) deficiency is a significant public health concern in many areas around the globe which has been associated with many immune-mediated diseases, including asthma. Severe asthma has been...
Eligibility Criteria
Inclusion
- Diagnosis of asthma
- age group between 18 and 65 years
- low level of 25-hydroxyvitamin D3 (25 D3) level less than 20ng/mL
Exclusion
- smoker patients
- less than 18 years old
- patient on Vitamin D supplementation already
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2014
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04443387
Start Date
April 1 2012
End Date
December 31 2014
Last Update
June 23 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.